Published in J Immunol on March 01, 1993
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Evolution of the immune system in humans from infancy to old age. Proc Biol Sci (2015) 1.31
T cell receptor V beta gene bias in rheumatoid arthritis. J Clin Invest (1993) 1.12
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A (1994) 1.07
Level of human TCRBV3S1 (V beta 3) expression correlates with allelic polymorphism in the spacer region of the recombination signal sequence. J Exp Med (1994) 0.99
Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis. Clin Exp Immunol (1995) 0.95
The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology (2001) 0.92
Population study of T cell receptor V beta gene usage in peripheral blood lymphocytes: differences in ethnic groups. Clin Exp Immunol (1993) 0.87
Definition of a human suppressor T-cell epitope. Proc Natl Acad Sci U S A (1994) 0.85
Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol (1994) 0.81
T-cell receptor Vbeta gene expression in experimental lupus nephritis. Immunology (1998) 0.80
Differential usage of T-cell receptor V beta gene families by CD4+ and CD8+ T cells in patients with CD8hi common variable immunodeficiency: evidence of a post-thymic effect. Immunology (1996) 0.78
T cell receptor genetics, autoimmunity and asthma. Thorax (1995) 0.76
T-cell receptor usage of interleukin-2-responsive peripheral gamma delta T cells. Immunology (1995) 0.76
Mycobacterium bovis BCG scar status and HLA class II alleles influence purified protein derivative-specific T-cell receptor V beta expression in pulmonary tuberculosis patients from southern India. Infect Immun (2003) 0.75
T cell receptor-Vβ repertoires in lung and blood CD4+ and CD8+ T cells of pulmonary sarcoidosis patients. BMC Pulm Med (2014) 0.75
No luck replicating the immune response in twins. Genome Med (2015) 0.75
Management of contact dermatitis due to nickel allergy: an update. Clin Cosmet Investig Dermatol (2009) 0.75
Persisting fetal clonotypes influence the structure and overlap of adult human T cell receptor repertoires. PLoS Comput Biol (2017) 0.75
Heterogeneity of rearranged T cell receptor V alpha and V beta gene transcripts in synovial fluid T cells of HLA-B27 positive reactive arthritis patients. Clin Rheumatol (1996) 0.75
Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology (1980) 5.86
The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets. Cell (1981) 4.16
Structure and function of the transforming genes of human adenoviruses and SV40. Cold Spring Harb Symp Quant Biol (1980) 1.60
Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity (1997) 1.52
Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy. J Pediatr (1997) 1.39
Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1a. Virology (1983) 1.22
Identification of adenovirus-type 12 gene products involved in transformation and oncogenesis. Virology (1982) 1.14
Dominant T-cell receptor beta-chain gene rearrangements indicate clonal expansion in the rheumatoid joint. Scand J Immunol (1990) 1.06
The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity (1998) 1.04
Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine (2001) 1.04
Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol (1999) 1.03
Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunol Rev (1991) 1.02
Cloning of the MCF1233 murine leukemia virus and identification of sequences involved in viral tropism, oncogenicity and T cell epitope formation. Virus Res (1994) 1.02
Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol (2000) 0.99
The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol (1998) 0.99
The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation. J Immunol (2001) 0.99
A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology (2000) 0.97
T cell receptors in rheumatoid arthritis. Arthritis Rheum (1995) 0.97
Binding of labeled initiation factor IF-1 to ribosomal particles and the relationship to the mode of IF-1 action in ribosome dissociation. Eur J Biochem (1978) 0.92
In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc Natl Acad Sci U S A (1997) 0.90
Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? Mol Carcinog (2001) 0.86
Definition of a human suppressor T-cell epitope. Proc Natl Acad Sci U S A (1994) 0.85
Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. J Immunol (1990) 0.84
Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. Eur J Immunol (1994) 0.84
Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+ CD45RO+ T lymphocytes on the basis of CDR3 diversity. Int Immunol (1994) 0.83
Non-random employment of V beta 6 and J beta gene elements and conserved amino acid usage profiles in CDR3 regions of human fetal and adult TCR beta chain rearrangements. Int Immunol (1994) 0.83
Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Br J Dermatol (2008) 0.83
T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome. Hum Immunol (2000) 0.82
Joint-derived T cells in rheumatoid arthritis proliferate to antigens present in autologous synovial fluid. Scand J Rheumatol Suppl (1995) 0.80
Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. J Immunol (1997) 0.80
T-cell receptor beta-chain gene rearrangements of T-cell populations expanded from multiple sites of synovial tissue obtained from a patient with rheumatoid arthritis. Scand J Immunol (1992) 0.79
Uveal melanoma: no expression of HLA-G. Invest Ophthalmol Vis Sci (2001) 0.79
Clonal dominance and selection for similar complementarity determining region 3 motifs among T lymphocytes responding to the HLA-DR3-associated Mycobacterium leprae heat shock protein 65-kd peptide 3-13. Hum Immunol (1995) 0.79
Locus-specific regulation of HLA-A and HLA-B expression is not determined by nucleotide variation in the X2 box promoter element. Blood (2001) 0.79
Direct assessment of junctional diversity in rearranged T cell receptor beta chain encoding genes by combined heteroduplex and single strand conformation polymorphism (SSCP) analysis. J Immunol Methods (1996) 0.78
Molecular analysis of the T-cell receptor beta-chain repertoire in early rheumatoid arthritis: heterogeneous TCRBV gene usage with shared amino acid profiles in CDR3 regions of T lymphocytes in multiple synovial tissue needle biopsies from the same joint. Eur J Clin Invest (1996) 0.78
Definition of a novel complementation group in MHC class II deficiency. Immunogenetics (1995) 0.78
T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantation. Transplant Proc (1993) 0.78
T cell development in a major histocompatibility complex class II-deficient patient. Eur J Immunol (1993) 0.78
Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patient. Transplantation (1994) 0.78
Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines. Immunogenetics (1999) 0.77
Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia. Viral Immunol (2001) 0.77
The regulation of HLA class I expression: is HLA-G the odd one out? Semin Cancer Biol (1999) 0.77
Modulation of the T cell compartment by blood transfusion. Effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vbeta usage. Transplantation (1997) 0.77
Therapeutic regulation of T cells in rheumatoid arthritis. Immunol Rev (1995) 0.77
Novel human MHC class I genes are expressed by tumour cell lines representing embryonic and extraembryonic tissues. J Immunogenet (1990) 0.77
Conserved TcR beta chain usage for a single MHC class II-restricted heat shock protein peptide. Immunogenetics (1998) 0.76
Identification of two distinct function gamma delta TCR complexes on the surface of a human T cell clone. Scand J Immunol (1995) 0.76
Usage of TCRAV and TCRBV gene families in human fetal and adult TCR rearrangements. Immunogenetics (1994) 0.76
T-cell receptor usage of interleukin-2-responsive peripheral gamma delta T cells. Immunology (1995) 0.76
Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia. Br J Haematol (1997) 0.76
Detection and characterization of HLA class I molecules in the supernatant of an hepatocarcinoma cell line and of EBV-transformed B cell lines. Hum Immunol (1999) 0.76
Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope. Int J Cancer (1997) 0.75
Long-term T cell immune reconstitution in 2 SCID patients after BMT. Hum Immunol (1998) 0.75
Cellular immune recognition of HLA-A*0201 following gene transfer into a human embryonal carcinoma cell line. Hum Immunol (1994) 0.75
Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+CD45RO+ T-lymphocytes on the basis of CDR3 diversity. Ann N Y Acad Sci (1995) 0.75
Evidence for selective usage of amino acids within CDR3 regions of T cell receptor V genes derived from synovial tissue-infiltrating CD4+CD45RO+ T-lymphocytes. Scand J Rheumatol Suppl (1995) 0.75
Skewing of TCR V genes to CD4+ and CD8+ subsets of T lymphocytes is not determined by amino acid composition of CDR3. Int Immunol (1997) 0.75
T-cell vaccination in patients with nickel allergic contact dermatitis. J Invest Dermatol (1995) 0.75
Limited restriction in alpha beta T-cell receptor usage of T-cell clones specific for myelin basic protein (a.a. 84-102) and hsp65 (a.a. 3-13) peptides within major histocompatibility complex-identical individuals. Ann N Y Acad Sci (1995) 0.75
HLA class I homologous transcripts in the human embryonal carcinoma cell line Tera-2. Immunogenetics (1990) 0.75
Monoclonal antibodies to human embryonal carcinoma cells: antigenic relationships of germ cell tumors. Lab Invest (1991) 0.75
The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine. Res Immunol (1990) 0.75
Selective usage of defined TCRBV genes in response to filarial antigens. Int Immunol (1997) 0.75